Supplementary Data from Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K <i>BRAF</i>-Mutant Melanoma — Inês Pires da Silva (2023) | RDL Network
Inês Pires da Silva, Kevin Wang, James S. Wilmott, Jeff Holst, Matteo S. Carlino, John Park, Camelia Quek, Matthew Wongchenko, Yibing Yan, Graham J. Mann, Douglas B. Johnson, Jennifer L. McQuade, Rajat Rai, Richard F. Kefford, Helen Rizos, Richard A Scolyer, Jean Yang, Georgina V. Long, Alexander M. Menzies
Inês Pires da Silva, Kevin Wang, James S. Wilmott, Jeff Holst, Matteo S. Carlino, John Park, Camelia Quek, Matthew Wongchenko, Yibing Yan, Graham J. Mann, Douglas B. Johnson, Jennifer L. McQuade, Rajat Rai, Richard F. Kefford, Helen Rizos, Richard A Scolyer, Jean Yang, Georgina V. Long, Alexander M. Menzies
Inês Pires da Silva, Kevin Wang, James S. Wilmott, Jeff Holst, Matteo S. Carlino, John Park, Camelia Quek, Matthew Wongchenko, Yibing Yan, Graham J. Mann, Douglas B. Johnson, Jennifer L. McQuade, Rajat Rai, Richard F. Kefford, Helen Rizos, Richard A Scolyer, Jean Yang, Georgina V. Long, Alexander M. Menzies
Vivek Subbiah, Igor Puzanov, Jean Yves Blay, Ian Chau, A. Craig Lockhart, Noopur Raje, Juergen Wolf, José Baselga, Funda Meric‐Bernstam, Jason Roszik, Eli L. Diamond, Gregory J. Riely, Eric J. Sherman, Todd Riehl, Bethany Pitcher, David M. Hyman
Vivek Subbiah, Igor Puzanov, Jean Yves Blay, Ian Chau, A. Craig Lockhart, Noopur Raje, Juergen Wolf, José Baselga, Funda Meric‐Bernstam, Jason Roszik, Eli L. Diamond, Gregory J. Riely, Eric J. Sherman, Todd Riehl, Bethany Pitcher, David M. Hyman
Discussion(0)
No comments yet. Be the first to comment.